CNTX-0066

N/A

Report date: 2025/09/29 16:01:35
NMEFirst In Class

Base Information

Drug NameCNTX-0066
Drug Alias NameCNTX-0066
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNerve growth factor receptor Trk-A antagonists
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCentrexion Therapeutics Corp
China Registration ClassN/A

Develop Information

Active CompaniesSanofiCentrexion Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A